Kelly Financial Services’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,300
| Closed | -$51.5K | – | 537 |
|
|
2024
Q2 | $51.5K | Hold |
2,300
| – | – | 0.02% | 222 |
|
|
2024
Q1 | $63.3K | Hold |
2,300
| – | – | 0.02% | 192 |
|
|
2023
Q4 | $70.1K | Hold |
2,300
| – | – | 0.03% | 168 |
|
|
2023
Q3 | $72.7K | Hold |
2,300
| – | – | 0.03% | 148 |
|
|
2023
Q2 | $93.8K | Hold |
2,300
| – | – | 0.04% | 127 |
|
|
2023
Q1 | $85.7K | Hold |
2,300
| – | – | 0.04% | 132 |
|
|
2022
Q4 | $80.2K | Hold |
2,300
| – | – | 0.04% | 134 |
|
|
2022
Q3 | $129K | Hold |
2,300
| – | – | 0.08% | 95 |
|
|
2022
Q2 | $119K | Hold |
2,300
| – | – | 0.06% | 105 |
|
|
2022
Q1 | $167K | Hold |
2,300
| – | – | 0.08% | 89 |
|
|
2021
Q4 | $272K | Hold |
2,300
| – | – | 0.12% | 62 |
|
|
2021
Q3 | $309K | Sell |
2,300
-370,093
| -99% | -$49.6M | 0.17% | 49 |
|
|
2021
Q2 | $2.3M | Buy |
372,393
+370,093
| +16,091% | +$2.29M | 0.09% | 69 |
|
|
2021
Q1 | $185K | Hold |
2,300
| – | – | 0.11% | 51 |
|
|
2020
Q4 | $125K | Hold |
2,300
| – | – | 0.09% | 57 |
|
|
2020
Q3 | $45.7K | Hold |
2,300
| – | – | 0.03% | 105 |
|
|
2020
Q2 | $48.3K | Hold |
2,300
| – | – | 0.04% | 92 |
|
|
2020
Q1 | $28.1K | Hold |
2,300
| – | – | 0.03% | 114 |
|
|
2019
Q4 | $33.7K | Hold |
2,300
| – | – | 0.03% | 114 |
|
|
2019
Q3 | $30.7K | Hold |
2,300
| – | – | 0.03% | 118 |
|
|
2019
Q2 | $37.7K | Hold |
2,300
| – | – | 0.03% | 97 |
|
|
2019
Q1 | $39.3K | Buy |
+2,300
| New | +$39.3K | 0.04% | 90 |
|